Revance Therapeutics, Inc(NASDAQ:RVNC) 
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection (D...
Website: http://www.revance.com
Founded: 1999
Full Time Employees: 193
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-08-08
P
O 2.98
H 3.08
L 2.82
C 2.95
V 2,716,027
10EMA 2.95
20EMA 2.95
60EMA 2.95
120EMA 2.95
250EMA 2.95